Kapitalo Investimentos Ltda Makes New $499,000 Investment in Chemed Co. (NYSE:CHE)

Kapitalo Investimentos Ltda purchased a new position in Chemed Co. (NYSE:CHEFree Report) during the 4th quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The institutional investor purchased 853 shares of the company’s stock, valued at approximately $499,000.

Other large investors have also recently modified their holdings of the company. GAMMA Investing LLC purchased a new stake in Chemed in the fourth quarter worth approximately $37,000. Principal Securities Inc. purchased a new stake in shares of Chemed in the fourth quarter worth $51,000. SRS Capital Advisors Inc. increased its stake in shares of Chemed by 110.6% in the fourth quarter. SRS Capital Advisors Inc. now owns 99 shares of the company’s stock worth $58,000 after purchasing an additional 52 shares in the last quarter. Covestor Ltd raised its position in shares of Chemed by 27.4% during the 3rd quarter. Covestor Ltd now owns 144 shares of the company’s stock valued at $75,000 after purchasing an additional 31 shares during the period. Finally, Larson Financial Group LLC boosted its holdings in Chemed by 86.9% in the 4th quarter. Larson Financial Group LLC now owns 157 shares of the company’s stock worth $92,000 after buying an additional 73 shares during the period. Hedge funds and other institutional investors own 95.85% of the company’s stock.

Insiders Place Their Bets

In related news, Director Patrick P. Grace sold 284 shares of the firm’s stock in a transaction dated Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total value of $153,638.32. Following the transaction, the director now owns 3,270 shares of the company’s stock, valued at approximately $1,769,004.60. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at this link. In other Chemed news, VP Brian C. Judkins sold 11,158 shares of the firm’s stock in a transaction dated Wednesday, March 20th. The shares were sold at an average price of $645.00, for a total transaction of $7,196,910.00. Following the transaction, the vice president now owns 1,422 shares of the company’s stock, valued at approximately $917,190. The transaction was disclosed in a legal filing with the Securities & Exchange Commission, which is available at the SEC website. Also, Director Patrick P. Grace sold 284 shares of Chemed stock in a transaction on Wednesday, June 12th. The shares were sold at an average price of $540.98, for a total value of $153,638.32. Following the completion of the transaction, the director now owns 3,270 shares in the company, valued at $1,769,004.60. The disclosure for this sale can be found here. Insiders have sold a total of 21,592 shares of company stock worth $13,424,584 over the last quarter. Company insiders own 3.32% of the company’s stock.

Chemed Stock Down 0.3 %

Chemed stock traded down $1.38 during midday trading on Tuesday, reaching $537.66. 5,237 shares of the stock traded hands, compared to its average volume of 80,232. The stock has a market cap of $8.14 billion, a P/E ratio of 28.99, a PEG ratio of 2.22 and a beta of 0.46. Chemed Co. has a 12 month low of $492.84 and a 12 month high of $654.62. The stock’s fifty day moving average is $570.54 and its 200-day moving average is $591.38.

Chemed (NYSE:CHEGet Free Report) last issued its quarterly earnings data on Wednesday, April 24th. The company reported $4.68 EPS for the quarter, missing analysts’ consensus estimates of $5.09 by ($0.41). Chemed had a return on equity of 30.52% and a net margin of 12.36%. The business had revenue of $589.23 million during the quarter, compared to analysts’ expectations of $587.18 million. On average, equities analysts predict that Chemed Co. will post 21.54 EPS for the current fiscal year.

Chemed Dividend Announcement

The firm also recently disclosed a quarterly dividend, which will be paid on Tuesday, June 18th. Shareholders of record on Thursday, May 30th will be given a $0.40 dividend. This represents a $1.60 annualized dividend and a yield of 0.30%. The ex-dividend date of this dividend is Thursday, May 30th. Chemed’s dividend payout ratio (DPR) is presently 8.61%.

Analyst Upgrades and Downgrades

Several equities analysts have recently commented on the company. Oppenheimer boosted their price objective on Chemed from $625.00 to $650.00 and gave the company an “outperform” rating in a research report on Thursday, February 29th. StockNews.com upgraded Chemed from a “hold” rating to a “buy” rating in a research note on Saturday, May 4th. Finally, Royal Bank of Canada lowered their target price on shares of Chemed from $712.00 to $697.00 and set an “outperform” rating on the stock in a report on Tuesday, May 21st.

Check Out Our Latest Research Report on Chemed

Chemed Company Profile

(Free Report)

Chemed Corporation provides hospice and palliative care services to patients through a network of physicians, registered nurses, home health aides, social workers, clergy, and volunteers primarily in the United States. The company operates in VITAS and Roto-Rooter segments. It offers plumbing, drain cleaning, excavation, water restoration, and other related services to residential and commercial customers through company-owned branches, independent contractors, and franchisees.

Further Reading

Want to see what other hedge funds are holding CHE? Visit HoldingsChannel.com to get the latest 13F filings and insider trades for Chemed Co. (NYSE:CHEFree Report).

Institutional Ownership by Quarter for Chemed (NYSE:CHE)

Receive News & Ratings for Chemed Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Chemed and related companies with MarketBeat.com's FREE daily email newsletter.